China SXT Pharmaceuticals (SXTC) Balance Sheet: Assets & Liabilities

China SXT Pharmaceuticals (SXTC) Balance Sheet

As of Mar 31, 2026 (end of fiscal 2026), China SXT Pharmaceuticals reported total assets of $34.75M and total liabilities of $5.05M. Shareholders' equity was $29.71M, up 92.4% from $15.44M a year earlier. Total debt stood at $999.57K against $28.32M in cash and short-term investments, a net cash position of $27.32M. That puts debt-to-equity at 0.03, compared with 0.06 a year earlier.

China SXT Pharmaceuticals Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for China SXT Pharmaceuticals, Inc. (SXTC) - Annual data in millions USD
Breakdown	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Current Assets
Cash and Cash Equivalents	28.18	18.10	12.07	17.37	15.52	13.33	7.29	9.13	0.56	0.07
Short-Term Investments	0.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	28.32	18.10	12.07	17.37	15.52	13.33	7.29	9.13	0.56	0.07
Accounts Receivable	0.93	1.90	1.31	1.34	3.33	7.77	10.65	4.93	3.91	3.21
Inventory	2.96	0.83	0.79	0.53	1.02	0.86	0.89	1.01	1.27	1.02
Other Current Assets	2.55	0.47	0.01	0.28	0.29	1.27	0.81	0.52	0.36	0.62
Total Current Assets	34.51	21.30	14.23	19.52	22.45	23.23	19.64	15.59	6.10	4.91
Non-Current Assets
Property, Plant & Equipment (Net)	0.24	0.36	0.56	1.27	1.59	1.79	1.90	1.81	1.49	0.49
Long-Term Investments	0.00	0.00	0.00	0.00	0.00	0.00	-0.44	-0.01	-0.01	0.00
Intangible Assets	0.01	0.01	0.02	0.03	0.04	0.05	0.05	0.06	0.06	0.04
Other Non-Current Assets	0.00	0.00	8.31	8.74	9.46	9.16	0.44	0.01	0.01	0.00
Total Non-Current Assets	0.24	0.37	8.89	10.03	11.09	11.31	2.07	1.88	1.56	0.53
Total Assets	34.75	21.66	23.13	29.55	33.55	34.55	21.70	17.47	7.66	5.43
Current Liabilities
Accounts Payable	0.50	1.16	1.28	1.38	1.48	1.46	1.94	1.69	2.41	1.26
Short-Term Debt	0.36	0.77	2.29	3.39	2.05	0.04	6.69	2.74	0.39	0.30
Current Portion of Long-Term Debt	-	0.01	0.02	0.01	0.01	0.04	-	-	-	-
Accrued Liabilities	3.30	2.94	1.23	3.14	0.85	3.05	-	-	-	-
Deferred Revenue	0.10	0.06	0.19	0.17	0.08	0.26	0.30	0.06	0.29	0.00
Other Current Liabilities	0.02	2.99	0.36	8.46	1.16	15.67	2.35	0.77	0.42	2.01
Total Current Liabilities	4.35	6.01	8.90	14.50	17.12	18.58	12.26	6.32	4.37	3.58
Non-Current Liabilities
Long-Term Debt	0.64	0.21	0.12	0.37	0.00	0.01	0.04	0.04	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	0.70	0.21	0.29	0.37	0.00	0.01	0.04	0.04	0.00	0.00
Total Liabilities	5.05	6.22	9.20	14.86	17.12	18.59	12.30	6.36	4.37	3.58
Stockholders' Equity
Common Stock	64.13	44.53	4.35	0.91	0.16	0.06	0.03	0.02	0.02	0.02
Retained Earnings	-34.22	-28.02	-24.71	-21.61	-15.69	-9.95	-7.20	3.08	1.54	0.36
Accumulated Other Comprehensive Income	-0.20	-1.08	-1.03	-0.20	0.96	0.53	-0.59	0.05	0.26	0.01
Additional Paid-in Capital	0.00	0.00	35.32	35.59	30.99	25.32	17.16	7.95	1.46	1.46
Shares Outstanding	0.01	0.00	0.00	0.00	0.00	-	-	-	-	-
Total Stockholders' Equity	29.71	15.44	13.93	14.69	16.42	15.96	9.40	11.11	3.29	1.85
Total Liabilities & Equity	34.75	21.66	23.13	29.55	33.55	34.55	21.70	17.47	7.66	5.43

Source: Company financial statements from annual and quarterly filings. Data as of Mar 31, 2026. Data sources and methodology

Frequently Asked Questions About China SXT Pharmaceuticals Balance Sheet

How much debt does China SXT Pharmaceuticals have?

China SXT Pharmaceuticals had total debt of $999.57K as of Mar 31, 2026, against $28.32M in cash and short-term investments. Its debt-to-equity ratio was 0.03. Total debt was $983.88K a year earlier.

What are China SXT Pharmaceuticals's total assets?

China SXT Pharmaceuticals reported total assets of $34.75M as of Mar 31, 2026, up 60.4% from $21.66M a year earlier. Total liabilities were $5.05M.

What is China SXT Pharmaceuticals's shareholders' equity?

China SXT Pharmaceuticals's shareholders' equity was $29.71M as of Mar 31, 2026, or about $2480.58 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition